Clinicopathological features and prognosis of malignant peripheral nerve sheath tumor: a retrospective study of 140 cases

Zhennan Yuan; Libin XU; Zhenguo Zhao; Songfeng XU; Xinxin Zhang; Ting Liu; Shuguang Zhang; Shengji YU

Return

Clinicopathological features and prognosis of malignant peripheral nerve sheath tumor: a retrospective study of 140 cases

VernacularTitle: 140例恶性外周神经鞘瘤患者的临床病理特征与预后分析
Author: Zhennan YUAN ¹ ; Libin XU ¹ ; Zhenguo ZHAO ¹ ; Songfeng XU ¹ ; Xinxin ZHANG ¹ ; Ting LIU ¹ ; Shuguang ZHANG ¹ ; Shengji YU ¹
Author Information

1. Department of Orthopaedics, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China
Publication Type:Clinical Trail
Keywords: Malignant peripheral nerve sheath tumors; Clinicopathological features; Prognosis; Recurrence; Metastasis
From: Chinese Journal of Oncology 2017;39(6):439-444
CountryChina
Language:Chinese
Abstract: Objective:To investigate the clinicopathological features and prognosis of malignant peripheral nerve sheath tumors (MPNST).
Methods:We retrospectively reviewed the clinical data of MPNST patients who were treated at Cancer Institute & Hospital, Chinese Academy of Medical Science from January 1999 to January 2016. A total of 140 patients with 66 male and 74 female with MPNST were enrolled in the study. The median age was 40 at the time of diagnosis. Survival analysis were estimated by Kaplan-Meier method and Log rank test. Multivariate analysis were estimated by Cox proportional hazards regression model.
Results:The median follow-up time was 43.0 months. The 3- and 5-year overall survival (OS) rates were 56.4% and 48.6%, respectively. The 3-year local recurrence (LR) rate and distant metastasis (DM) rates were 42.9% and 49.3%, respectively. Univariate analysis showed that the tumor location, AJCC stage, S-100, radiotherapy and margin status affected 5-year OS rate (all P<0.05). The tumor location, AJCC stage, S-100, Ki-67 staining, margin status, radiotherapy and chemotherapy affected 3-year LR rate (all P<0.05). The tumor location, AJCC stage, S-100, Ki-67 staining and margin status affected 3-year DM rate (all P<0.05). Multivariate analysis showed that the tumor location, AJCC stage, S-100 were independent factors for 5-year OS rate (all P<0.05). The tumor location, Ki-67 staining and chemotherapy were independent factors for LR (all P<0.05) while the AJCC stage, margin status and Ki-67 staining were independent factors for DM (all P<0.05).
Conclusions:MPSNT is an aggressive tumor with poor prognosis. Multiple factors were identified in this study. Patients with the tumor located at head and neck, advanced AJCC stage and negative S-100 usually have a low 5-year overall survival rate. Patients with the tumor located at head and neck, Ki-67 staining ≥ 20% and without chemotherapy had a higher tendency of local recurrence. Poor prognosis factors for DM were advanced AJCC stage, positive margin and Ki-67 staining ≥ 20%.